Lily Chang, autor en Bean watcher

Aug

13

2024

Deliveroo posts profit, shares rise on demand rebound

British food delivery giant Deliveroo has defied industry odds to post its first-ever profit. The company reported a net profit of £1.3 million for the first half of the year, a stark contrast to the £82.9 million loss it suffered in the same period last year. This turnaround can be attributed to a recovery in consumer demand, with order frequency and customer loyalty increasing. Deliveroo's gross transaction value rose 6% to £3.7 billion, while revenue increased 2% to £1,028.2 million. The positive financial performance has boosted Deliveroo’s share price by 10%, offering a glimmer of hope to investors who have…

Aug

13

2024

By Lily Chang

China’s Leadership Supports President Xi’s Vision for a Technologically Advanced Economy

Science and Technology

BEIJING — In a recent crucial meeting, the Chinese Communist Party endorsed President Xi Jinping’s ambitious plan to strengthen the country’s technological power and enhance its national security. Party meeting summary After their high-level meeting, the Party issued a brief statement stressing their commitment to major technological advances. Detailed insights from the discussions are expected to be released soon. Vision for 2029 The Party's goals are set to be completed by the 80th anniversary of the People's Republic of China in 2029, focusing on achieving technological autonomy in an era of limited access to Western technologies, including sophisticated processors and…

Aug

12

2024

By Lily Chang

Eli Lilly’s profits soar on the success of Mounjaro and Zepbound

Investments and Business

Pharmaceutical giant Eli Lilly delivered a stellar second-quarter performance, beating analysts’ expectations and raising its full-year outlook by a whopping $3 billion. The company’s flagship diabetes drug, Mounjaro, and its weight-loss counterpart, Zepbound, were the main drivers of the stellar growth. Mounjaro and Zepbound, both incretin drugs, have seen unprecedented demand, leading to supply constraints that Eli Lilly is aggressively addressing. The company has invested heavily in expanding manufacturing capacity, resulting in a 50% increase in production of these drugs in the second half of 2024 versus the prior year. Despite supply challenges, Eli Lilly’s revenues increased 36% year-over-year to…

Aug

12

2024

By Lily Chang

U.S. Hesitates to Recognize Edmundo González as President-Elect Amid Venezuela Election Discussions

Politics

In Washington, the US continues to closely monitor Venezuela's political dynamics, emphasizing the dialogue it has sustained before modifying the sanctions regime. This position was detailed by Frank Mora, US spokesman at the Organization of American States (OAS), in an interview with Voice of America. Mora stressed the importance of continued vigilance in Venezuelan affairs and advocated respecting the election results after both Nicolás Maduro and his challenger, Edmundo González, claimed victory. "Our assessment is clear: Edmundo González has garnered enough votes to be considered the winner. However, prematurely considering him 'president-elect' could complicate ongoing diplomatic efforts," he said. The…